Use of System XC-Inhibitor for Treating Statin-Induced Myalgia
AssigneeExerkine Corporation
InventorsMark Tarnopolsky, Thomas Hawke
Life of this patent
Estimating the term…
Abstract
A method of reducing glutamate efflux from skeletal muscle by inhibiting system Xc- activity is provided. The method is useful for the treatment of statin-induced myalgia. Pharmaceutical compositions useful to treat statin-induced myalgia are also provided, as well as a kit.
Claims30
A method of reducing glutamate efflux from muscle cells comprising the step of administering a system Xc- inhibitor to the cells.
(canceled)
(canceled)
(canceled)
(canceled)
A method of treating statin-induced myalgia in a mammal comprising the step of administering to the mammal a system Xc- inhibitor.
(canceled)
(canceled)
(canceled)
A composition useful for treating statin-induced myalgia in a mammal comprising a system Xc- inhibitor in combination with i) one or more additional Xc-inhibitors;
- ii) a statin;
- or iii) a second therapeutic agent.
(canceled)
(canceled)
A kit useful to treat statin-induced myalgia comprising a system Xc-inhibitor and a statin.
(canceled)
Dependencies are inferred from the claim text.